6/27/23 18:30 | 6/27/23 | NOVN | Health | Drug | Pharmaceutical Preparations | Sanders Machelle | NC | D | | S | -5 | 0.4082 | 0 | -12 | -31 | 25 | D | | | | | | | | | | | | | | |
6/8/23 21:22 | 6/7/23 | NOVN | Health | Drug | Pharmaceutical Preparations | Gay John M. | NC | O | CFO | M.d | 0 | 0.00 | 0 | 65 | | 47 | D | | | | | | | | | | | | | | |
6/8/23 21:22 | 6/7/23 | NOVN | Health | Drug | Pharmaceutical Preparations | Geer W Kent | NC | D | | M.d | 0 | 0.00 | 0 | 36 | 999% | 38 | D | | | | | | | | | | | | | | |
6/8/23 21:21 | 6/7/23 | NOVN | Health | Drug | Pharmaceutical Preparations | Sanders Machelle | NC | D | | M.d | 0 | 0.00 | 0 | 36 | 999% | 37 | D | | | | | | | | | | | | | | |
6/8/23 21:21 | 6/7/23 | NOVN | Health | Drug | Pharmaceutical Preparations | Bierman James L | NC | D | | M.d | 0 | 0.00 | 0 | 36 | 903 | 40 | D | | | | | | | | | | | | | | |
6/8/23 21:21 | 6/7/23 | NOVN | Health | Drug | Pharmaceutical Preparations | Keegan Robert J | NC | D | | M.d | 0 | 0.00 | 0 | 36 | 573 | 42 | D | | | | | | | | | | | | | | |
6/8/23 21:21 | 6/7/23 | NOVN | Health | Drug | Pharmaceutical Preparations | Skolsky Steven D | NC | D | | M.d | 0 | 0.00 | 0 | 36 | New | 36 | D | | | | | | | | | | | | | | |
4/11/22 16:15 | 4/7/22 | NOVN | Health | Drug | Pharmaceutical Preparations | Bierman James L | NC | D | | P | 3 | 3.45 | 0 | 1 | 33 | 4 | D | | | | | | | | | | | | | | |
3/30/22 17:23 | 3/28/22 | NOVN | Health | Drug | Pharmaceutical Preparations | Bierman James L | NC | D | | P | 3 | 3.45 | 0 | 1 | 50 | 3 | D | | | | | | | | | | | | | | |
3/28/22 17:01 | 3/25/22 | NOVN | Health | Drug | Pharmaceutical Preparations | Bierman James L | NC | D | | P | 7 | 3.55 | 0 | 2 | New | 2 | D | | | | | | | | | | | | | | |
3/22/22 17:26 | 3/18/22 | NOVN | Health | Drug | Pharmaceutical Preparations | Palmour John W | NC | D | | P | 36 | 3.64 | 0 | 10 | 12 | 97 | D | | | | | | | | | | | | | | |
3/22/22 17:25 | 3/18/22 | NOVN | Health | Drug | Pharmaceutical Preparations | Gay John M. | NC | O | CFO | P | 4 | 3.50 | 0 | 1 | 67 | 3 | D | | | | | | | | | | | | | | |
3/18/22 17:52 | 3/16/22 | NOVN | Health | Drug | Pharmaceutical Preparations | Palmour John W | NC | D | | P.m | 33 | 3.34 | 0 | 10 | 13 | 87 | D | | | | | | | | | | | | | | |
3/29/21 16:07 | 3/26/21 | NOVN | Health | Drug | Pharmaceutical Preparations | Stafford Paula B | NC | DO | P,CEO | P | 100 | 1.43 | 0 | 70 | 87 | 151 | D | | | | | | | | | | | | | | |
3/5/20 16:16 | 3/3/20 | NOVN | Health | Drug | Pharmaceutical Preparations | Palmour John W | NC | D | | P.d | 0 | 0.00 | 0 | 200 | 35 | 768 | D | | | | | | | | | | | | | | |
3/5/20 16:16 | 3/3/20 | NOVN | Health | Drug | Pharmaceutical Preparations | Sanders Machelle | NC | D | | P.d | 0 | 0.00 | 0 | 7 | New | 7 | D | | | | | | | | | | | | | | |
7/2/19 21:45 | 6/28/19 | NOVN | Health | Drug | Pharmaceutical Preparations | Malin Life Sciences Holdings Ltd | L2 | T | | S.m | -68 | 2.71 | 0 | -25 | -1 | 2,598 | I | | | | | | | | | | | | | | |
5/30/19 17:25 | 5/29/19 | NOVN | Health | Drug | Pharmaceutical Preparations | Martin G. Kelly | NC | DO | CEO | P | 3 | 1.97 | 0 | 2 | 1 | 105 | I | | | | | | | | | | | | | | |
5/29/19 09:00 | 5/28/19 | NOVN | Health | Drug | Pharmaceutical Preparations | Martin G. Kelly | NC | DO | CEO | P | 8 | 2.15 | 0 | 4 | 4 | 104 | I | | | | | | | | | | | | | | |
5/29/19 08:59 | 5/24/19 | NOVN | Health | Drug | Pharmaceutical Preparations | Palmour John W | NC | D | | P | 44 | 2.20 | 0 | 20 | 4 | 568 | D | | | | | | | | | | | | | | |
5/23/19 08:32 | 5/21/19 | NOVN | Health | Drug | Pharmaceutical Preparations | Geer W Kent | NC | D | | P | 10 | 1.90 | 0 | 5 | 46 | 16 | D | | | | | | | | | | | | | | |
5/23/19 08:31 | 5/22/19 | NOVN | Health | Drug | Pharmaceutical Preparations | Ingram Robert Alexander | NC | D | | P | 111 | 2.21 | 0 | 50 | 42 | 170 | D | | | | | | | | | | | | | | |
5/21/19 16:54 | 5/17/19 | NOVN | Health | Drug | Pharmaceutical Preparations | Novak Andrew | NC | O | VP,Accou | P | 8 | 1.47 | 0 | 5 | 415 | 7 | I | | | | | | | | | | | | | | |
5/21/19 16:53 | 5/17/19 | NOVN | Health | Drug | Pharmaceutical Preparations | Gay John M. | NC | O | VP,Finan | P | 22 | 1.50 | 0 | 15 | 999% | 15 | D | | | | | | | | | | | | | | |
5/21/19 16:52 | 5/17/19 | NOVN | Health | Drug | Pharmaceutical Preparations | Stafford Paula B | NC | DO | P,COO | P.m | 155 | 1.92 | 0 | 81 | New | 81 | D | | | | | | | | | | | | | | |
5/21/19 16:51 | 5/17/19 | NOVN | Health | Drug | Pharmaceutical Preparations | Martin G. Kelly | NC | DO | CEO | P | 86 | 1.43 | 0 | 60 | 150 | 100 | M | | | | | | | | | | | | | | |
10/1/18 16:34 | 9/28/18 | NOVN | Health | Drug | Pharmaceutical Preparations | Ingram Robert Alexander | NC | D | | P | 142 | 2.84 | 0 | 50 | 72 | 120 | D | | | | | | | | | | | | | | |
9/27/18 16:24 | 9/26/18 | NOVN | Health | Drug | Pharmaceutical Preparations | Martin G. Kelly | NC | DO | CEO | P | 27 | 2.73 | 0 | 10 | 33 | 40 | D | | | | | | | | | | | | | | |
8/24/18 08:43 | 8/22/18 | NOVN | Health | Drug | Pharmaceutical Preparations | Palmour John W | NC | D | | P | 53 | 2.66 | 0 | 20 | 4 | 548 | D | | | | | | | | | | | | | | |
8/24/18 08:41 | 8/22/18 | NOVN | Health | Drug | Pharmaceutical Preparations | Hunter Jeff N | NC | O | EVP,Chie | M.d | 13 | 1.12 | 0 | 12 | 5 | 228 | D | | | | | | | | | | | | | | |
8/23/18 16:32 | 8/21/18 | NOVN | Health | Drug | Pharmaceutical Preparations | Martin G. Kelly | NC | DO | CEO | P | 81 | 2.71 | 0 | 30 | New | 30 | D | | | | | | | | | | | | | | |
9/18/17 16:35 | 9/15/17 | NOVN | Health | Drug | Pharmaceutical Preparations | Hodges William L | NC | O | Interim | M.d | 30 | 6.03 | 0 | 5 | New | 5 | D | | | | | | | | | | | | | | |
8/29/17 16:37 | 8/25/17 | NOVN | Health | Drug | Pharmaceutical Preparations | Ingram Robert Alexander | NC | D | | P.m | 55 | 4.57 | 0 | 12 | 21 | 70 | D | | | | | | | | | | | | | | |
8/25/17 16:33 | 8/23/17 | NOVN | Health | Drug | Pharmaceutical Preparations | Palmour John W | NC | D | | P | 48 | 3.99 | 0 | 12 | 2 | 528 | D | | | | | | | | | | | | | | |
9/28/16 18:27 | 9/26/16 | NOVN | Health | Drug | Pharmaceutical Preparations | Malin Life Sciences Holdings Ltd | L2 | T | | P.d | 8,800 | 11.00 | 18 | 800 | 44 | 2,623 | I | | | | | | | | 4 | -4 | -11 | -7 | 16 | -75 | |